Ann
In the original manuscript, there were some errors.
The corrected paragraph and Figure 3 legend are as below.
results

patient enrollment
We enrolled 43 male patients between May 2008 and August 2014, pretreated with a median 4 (2-9) regimens (Table 2) . Two female patients enrolled are not included in this analysis.
Twenty patients had absolute cisplatin refractory disease (defined as PD as best response), 17 refractory disease (relapse/PD within 4 weeks) disease and 6 had cisplatinsensitive disease.
Disease was nonresponsive in 24 patients (22 PD, 2 SD), and responsive in 19 patients (8 PRm 
